OPKO Health, Inc. OPK is well-poised for growth in the coming quarters, courtesy of its potential in RAYALDEE. The optimism ...

Cencora, Inc. (NYSE: COR) today announced that it plans to release its results for the Second Quarter of Fiscal 2025 on Wednesday, May 7, 2025, prior to the opening of trading on the New York Stock ...

According to a Bloomberg report, the French-based Walden Group, a company specializing in pharmaceutical logistics, is ...

The busy Ringbahn viaduct on the A100 motorway (Berlin's city ring road) is only accessible to a limited extent for safety ...

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. The popular research ...

Cencora (COR) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

AbbVie, Danaher, Thermo Fisher Scientific, Cognizant Technology Solutions, Vertex Pharmaceuticals, Alnylam Pharmaceuticals, ...

The 11 health insurance providers stocks we track reported a satisfactory Q4. As a group, revenues beat analysts’ consensus estimates by 2.3% while next quarter’s revenue guidance was in line.

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch Automation brings you the latest, most pertinent content at record speed and with ...

Cencora COR +0.57% Get Free Report has outperformed the market over the past 10 years by 7.55% on an annualized basis ...

Die DHL und das US-Logistikunternehmen Cencora gehören dem Vernehmen nach zu den potenziellen Interessenten für den ...

Legendary investor and famous contrarian Sir John Templeton once said, "The time of maximum pessimism is the best time to buy." The S&P 500 is down 3.7% through March 20, and though we are far ...